In vivo confocal microscopy (IVCM) backscatter measurements is a usefull measurement to decide whether patients with FED and cataract should undergo either a phaco or a triple procedure.
ID
Bron
Verkorte titel
Aandoening
- Fuchs' endothelial dystrophy
- Cataract
Ondersteuning
Postbus 93245
2509 AE Den Haa
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
At one month: the number of patients (not) requiring posterior lamellar keratoplasty (PLK); this in relation to the preoperatively measured corneal backscatter (on in vivo confocal microscope).
Achtergrond van het onderzoek
Rationale: Fuchs' endothelial dystrophy (FED) is associated with a reduction of the corneal endothelial cell density (ECD). As cataract surgery may enhance cell loss, and lead to corneal edema and reduced vision, it may become necessary to restore vision by posterior lamellar keratoplasty (PLK). With advanced FED, the ECD itself happens to be an unreliable parameter. Instead, we will evaluate backscatter on in vivo confocal microscopy (IVCM) as a possible decisive preoperative measure for the clinical choice between phaco-emulsification or triple procedure in eyes with FED and cataract.
Objective: To study IVCM backscatter measurements as a usefull measurement to decide between surgical indications.
Study design: Prospective observational trial.
Study population: Patients with advanced FED indicated for cataract surgery.
Intervention: None.
Main study parameters/endpoints: Preoperative corneal backscatter; postoperative
number of patients requiring PLK (y/n).
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Particpants do not benefit. Assessments will be scheduled at the time of regular visits. Additional measurements include two IVCM assessments which involve contact with the cornea. Extra measurements will take about two times one hour.
Doel van het onderzoek
In vivo confocal microscopy (IVCM) backscatter measurements is a usefull measurement to decide whether patients with FED and cataract should undergo either a phaco or a triple procedure.
Onderzoeksopzet
Preop, 1 month.
Onderzoeksproduct en/of interventie
None.
Publiek
Rotterdam Ophthalmic Institute, The Rotterdam Eye Hospital
PO Box 70030
Rotterdam 3000 LM
The Netherlands
tel. 010 4023449
roi@oogziekenhuis.nl
Wetenschappelijk
Rotterdam Ophthalmic Institute, The Rotterdam Eye Hospital
PO Box 70030
Rotterdam 3000 LM
The Netherlands
tel. 010 4023449
roi@oogziekenhuis.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
- Age ≥ 18 years.
- Informed consent.
- FED stage ≥ 2.
- Cataract requiring surgery.
- Visual acuity (VA) < 0.5.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
- Indication for triple procedure.
- History of other ocular disorders affecting VA.
- History of intra-ocular, corneal or refractive surgery.
- Severe nystagmus.
- Corneal opacity in the pre-pupillary region not related to FED.
- Corneal neovascularization > 1 quadrant.
- Amblyopia.
- Expected VA after surgery < 0.6.
- Fellow eye already included in this study.
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL5067 |
NTR-old | NTR5198 |
CCMO | NL52626.078.15 |
OMON | NL-OMON42593 |